Safety and Tolerance of Local Heat Application in the Paralyzed Area of Patients With Complete Paraplegia (DecuHeat)

November 10, 2020 updated by: Swiss Paraplegic Centre Nottwil
Preconditioning of regional skin is known to reduce post surgery complications due to increased perfusion and better skin condition. The aim of this study is to prove that local heating through a standardized device in patients with spinal cord injury induces no burnings or other relevant side effects. The investigators expect an increased regional perfusion, temperature and redness.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nottwil, Switzerland
        • Swiss Paraplegic Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • men and women
  • aged from 18 to 65 years
  • paraplegia Th2-Th12
  • spinal cord injury had occurred >12 weeks ago

Exclusion Criteria:

  • infections
  • fever
  • diabetes
  • heart failure stadium III
  • renal insufficiency stadium III.
  • scars, wounds or other injuries in the area of treatment
  • skin type V and VI on Fitzpatrick scale

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: HydroSun
application of ultraviolet light for 30 minutes
a skin area of the lower limb will be treated three times with ultraviolet light emitted by a halogen lamp
ACTIVE_COMPARATOR: Hilotherm
application of heat (maximum of 43°C) for 30 minutes
a skin area of the lower limb will be treated three times with heat applied by a sleeve

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
presence of burn injury
Time Frame: up to 24 hours
grade 1 (hyperemia, redness), grade 2 a/b (blisters) and grade 3 (necrosis)
up to 24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood perfusion
Time Frame: before and 1min after the application of light or heat
perfusion (PeriFlux System 5000) in perfusion units
before and 1min after the application of light or heat
skin surface temperature
Time Frame: before and 1min after the application of light or heat
measuring surface temperature with thermometer
before and 1min after the application of light or heat
skin redness
Time Frame: before and 1min after the application of light or heat
visual inspection
before and 1min after the application of light or heat

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2016

Primary Completion (ACTUAL)

June 1, 2017

Study Completion (ACTUAL)

August 1, 2017

Study Registration Dates

First Submitted

December 7, 2016

First Submitted That Met QC Criteria

December 20, 2016

First Posted (ESTIMATE)

December 23, 2016

Study Record Updates

Last Update Posted (ACTUAL)

November 12, 2020

Last Update Submitted That Met QC Criteria

November 10, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2014-05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perfusion; Complications

Clinical Trials on HydroSun

3
Subscribe